{"drugs":["Hyaluronic Acid","Monovisc","Orthovisc"],"mono":{"0":{"id":"928028-s-0","title":"Generic Names","mono":"Hyaluronic Acid"},"1":{"id":"928028-s-1","title":"Dosing and Indications","sub":{"0":{"id":"928028-s-1-4","title":"Adult Dosing","mono":"<b>Osteoarthritis of knee:<\/b> 30 mg per 2 mL (contents of prefilled syringe) INTRA-ARTICULARLY into the knee once weekly for a total of 3 to 4 injections (as a series of 3 to 4 injections each 1 week apart) "},"1":{"id":"928028-s-1-5","title":"Pediatric Dosing","mono":"safety and effectiveness not established in pediatric patients "},"3":{"id":"928028-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Osteoarthritis of knee<br\/>"}}},"3":{"id":"928028-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928028-s-3-9","title":"Contraindications","mono":"<ul><li>hypersensitivity to hyaluronic acid, or hyaluronate preparations (Bionect(R), Orthovisc(R))<\/li><li>knee joint infections or skin disease at injection site, active (Orthovisc(R))<\/li><li>allergy to avian or avian-derived products, including eggs, feathers, or poultry (Orthovisc(R))<\/li><\/ul>"},{"id":"928028-s-3-10","title":"Precautions","mono":"<ul><li>concomitant use of disinfectants containing quarternary ammonium salts should be avoided (hyaluronic acid can precipitate in their presence) (Bionect(R), Orthovisc(R))<\/li><li>increased inflammation in injected knee, transient, has been reported (Orthovisc(R))<\/li><li>sensitization may occur, particularly with prolonged use; discontinue use (Bionect(R))<\/li><\/ul>"},{"id":"928028-s-3-11","title":"Pregnancy Category","mono":"Fetal risk cannot be ruled out. (TH)<br\/>"},{"id":"928028-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"928028-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Injection site pain (2.5%), Injection site reaction (0.2%)<\/li><li><b>Musculoskeletal:<\/b>Arthralgia (12.6%)<\/li><\/ul>"},"6":{"id":"928028-s-6","title":"Drug Name Info","sub":{"0":{"id":"928028-s-6-17","title":"US Trade Names","mono":"<ul><li>Orthovisc<\/li><li>Monovisc<\/li><\/ul>"},"2":{"id":"928028-s-6-19","title":"Class","mono":"Cartilaginous Defect Repair Agent<br\/>"},"3":{"id":"928028-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"928028-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"928028-s-7","title":"Mechanism Of Action","mono":"Hyaluronic acid, also known as hyaluronan, is a high molecular weight polysaccharide derived from chicken combs that is used to relieve joint pains. It is necessary for the joint to work properly and it exerts its effect by replacing the depleted hyaluronan, which acts as a lubricant and shock absorber, in arthritic joints.<br\/>"},"9":{"id":"928028-s-9","title":"Administration","mono":"<b>Intra-articular<\/b><br\/><ul><li>attach a small gauge needle (18- to 21-gauge) to tip of the syringe; inject the full contents of syringe into one knee only<\/li><li>if treatment is bilateral, use a separate syringe for each knee<\/li><\/ul>"},"10":{"id":"928028-s-10","title":"Monitoring","mono":"reduction in pain associated with osteoarthritis of the knee is indicative of efficacy<br\/>"},"11":{"id":"928028-s-11","title":"How Supplied","mono":"<ul><li><b>Monovisc<\/b><br\/>Injection Solution: 22 MG\/ML<br\/><\/li><li><b>Orthovisc<\/b><br\/>Injection Solution: 15 MG\/ML<br\/><\/li><\/ul>"},"13":{"id":"928028-s-13","title":"Clinical Teaching","mono":"<ul><li>Instruct patient to avoid strenuous or prolonged weight-bearing activity for 48 hours after intraarticular injection.<\/li><li>This drug may cause injection-site pain, joint stiffness or swelling, and arthralgia.<\/li><li>Advise patient to report signs\/symptoms of infection.<\/li><\/ul>"}}}